HIDEA syndrome; P4HTM; ROHHAD; central hypoventilation; childhood obesity; hypothalamic dysfunction and autonomic dysregulation; rapid-onset obesity with hypoventilation; Genetics (clinical); Genetics; Molecular Medicine
Abstract :
[en] Context: ROHHAD syndrome presents a significant resemblance to HIDEA syndrome. The latter is caused by biallelic loss-of-function variants in the P4HTM gene and encompasses hypotonia, intellectual disabilities, eye abnormalities, hypoventilation, and dysautonomia. We report the first patient identified with HIDEA syndrome from our ROHHAD cohort. Clinical case: Our patient was a 21-month-old girl who had a history of severe respiratory infections requiring intensive care, hypotonia, abnormal eye movements, and rapid weight gain. Polysomnography identified severe central hypoventilation. During her follow-up, a significant psychomotor delay and the absence of language were gradually observed. The prolactin levels were initially increased. Hypothermia was reported at 4 years. Exome sequencing identified a new homozygous truncating P4HTM variant. Discussion: Our patient met the diagnosis criteria for ROHHAD, which included rapid weight gain, central hypoventilation appearing after 1.5 years of age, hyperprolactinemia suggesting hypothalamic dysfunction, and autonomic dysfunction manifesting as strabismus and hypothermia. However, she also presented with severe neurodevelopmental delay, which is not a classic feature of ROHHAD syndrome. HIDEA syndrome presents similarities with ROHHAD, including hypoventilation, obesity, and dysautonomia. To date, only 14% of endocrinological disturbances have been reported in HIDEA patients. Better delineation of both syndromes is required to investigate the eventual involvement of P4HTM, a regulator of calcium dynamics and gliotransmission, in ROHHAD patients. Conclusion: In the case of clinical evidence of ROHHAD in a child with abnormal neurological development or eye abnormalities, we suggest that the P4HTM gene be systematically interrogated in addition to the analysis of the PHOX2B gene. A better delineation of the natural history of HIDEA is required to allow further comparisons between features of HIDEA and ROHHAD. The clinical similarities could potentially orient some molecular hypotheses in the field of ROHHAD research.
Disciplines :
Genetics & genetic processes
Author, co-author :
Harvengt, Julie ; Centre Hospitalier Universitaire de Liège - CHU > > Service de génétique
Lumaka, A; Human Genetics Department, CHU of Liège, Liège, Belgium ; GIGA Research, University of Liège, Liège, Belgium
Fasquelle, Corinne ; Centre Hospitalier Universitaire de Liège - CHU > > Service de génétique
CABERG, Jean-Hubert ; Centre Hospitalier Universitaire de Liège - CHU > > Service de génétique
Mastouri, M; Pediatric Department, Hospital Center of Luxembourg, Luxembourg City, Luxembourg
JANSSEN, Aurélie ; Centre Hospitalier Universitaire de Liège - CHU > > Service de pédiatrie
Palmeira, Leonor ; Centre Hospitalier Universitaire de Liège - CHU > > Service de génétique
Bours, Vincent ; Centre Hospitalier Universitaire de Liège - CHU > > Service de génétique
Language :
English
Title :
HIDEA syndrome: A new case report highlighting similarities with ROHHAD syndrome.
Barclay S. F. Rand C. M. Nguyen L. Wilson R. J. A. Wevrick R. Gibson W. T. et al. (2018). ROHHAD and prader-willi syndrome (PWS): Clinical and genetic comparison. Orphanet J. Rare Dis. 13, 124. 10.1186/s13023-018-0860-0
Bougnères P. Pantalone L. Linglart A. Rothenbuhler A. (2008). Endocrine manifestations of the rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, and neural tumor syndrome in childhood. J. Clin. Endocrinol. Metab. 93 (10), 3971–3980. 10.1210/jc.2008-0238
Byts N. Sharma S. Laurila J. Paudel P. Miinalainen I. Ronkainen V. P. et al. (2021). Transmembrane Prolyl 4-hydroxylase is a novel regulator of calcium signaling in astrocytes. eNeuro 8 (1), ENEURO.0253–20.2020. 10.1523/ENEURO.0253-20.2020
Desse B. Tran A. Butori M. Marchal S. Afanetti M. Barthelemy S. et al. (2022). ROHHAD syndrome without rapid-onset obesity: A diagnosis challenge. Front. Pediatr. 10, 910099. 10.3389/fped.2022.910099
Harvengt J. Gernay C. Matouri M. Farhat N. Lebrethon M. C. Seghaye M. C. et al. (2020). ROHHAD(NET) syndrome: Systematic review of the clinical timeline and recommendations for diagnosis and prognosis. JCEM 105 (7), dgaa247–2131. 10.1210/clinem/dgaa247
Hay E. Wilson L. C. Hoskins B. Samuels M. Munot P. Rahman S. (2021). Biallelic P4HTM variants associated with HIDEA syndrome and mitochondrial respiratory chain complex I deficiency. Eur. J. Hum. Genet. 29 (10), 1536–1541. 10.1038/s41431-021-00932-8
Ize-Ludlow D. Gray J. A. Sperling M. A. Berry-Kravis E. M. Milunsky J. M. Farooqi I. S. et al. (2007). Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation presenting in childhood. PEDIATRICS 120 (1), e179–e188. 10.1542/peds.2006-3324
Järvelä I. Määttä T. Acharya A. Leppala J. Jhangiani S. N. Arvio M. et al. (2021). Exome sequencing reveals predominantly de novo variants in disorders with intellectual disability (ID) in the founder population of Finland. Hum. Genet. 140 (7), 1011–1029. 10.1007/s00439-021-02268-1
Jin S. Diano S. (2018). Mitochondrial dynamics and hypothalamic regulation of metabolism. Endocrinology 159 (10), 3596–3604. 10.1210/en.2018-00667
Kaasinen E. Rahikkala E. Koivunen P. Miettinen S. Wamelink M. M. C. Aavikko M. et al. (2014). Clinical characterization, genetic mapping and whole-genome sequence analysis of a novel autosomal recessive intellectual disability syndrome. Eur. J. Med. Genet. 57 (10), 543–551. 10.1016/j.ejmg.2014.07.002
Kraatari-Tiri M. Soikkonen L. Myllykoski M. Jamshidi Y. Karimiani E. G. Komulainen-Ebrahim J. et al. (2022). HIDEA syndrome is caused by biallelic, pathogenic, rare or founder P4HTM variants impacting the active site or the overall stability of the P4H-TM protein. Clin. Genet. 102 (5), 444–450. 10.1111/cge.14203
Lim A. M. Tan P. L. Visruthan N. K. Fong N. Viegelmann G. C. Tan Y. H. (2022). HIDEA syndrome: A rare cause of congenital hypoventilation in a premature infant. Pediatr. Pulmonol. 11, 1826–1829. 10.1002/ppul.25966
Maddirevula S. Ben-Omran T. AlMureikhi M. Eyaid W. Arabi H. Alkuraya H. et al. (2020). Further delineation of HIDEA syndrome. Am. J. Med. Genet. 182 (12), 2999–3006. 10.1002/ajmg.a.61885
Rahikkala E. Myllykoski M. Hinttala R. Vieira P. Nayebzadeh N. Weiss S. et al. (2019). Biallelic loss-of-function P4HTM gene variants cause hypotonia, hypoventilation, intellectual disability, dysautonomia, epilepsy, and eye abnormalities (HIDEA syndrome). Genet. Med. 21 (10), 2355–2363. 10.1038/s41436-019-0503-4
Williams K. E. Sormunen R. Klaus S. J. Koivunen P. Tiainene P. Hyvarinen J. et al. (2007). An Endoplasmic Reticulum Transmembrane Prolyl 4-Hydroxylase is induced by hypoxa and acts on hypoxia-inducible Factor alpha. J. Biol. Chem. 282 (42), 30544–30552. 10.1074/jbc.m704988200